Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant

Data Published in BMC Veterinary Research shows that OKV-119 exenatide implant reduced feline weight


Felines share many pathophysiologic obesity phenotypes with humans, further supporting clinical...

Related Keywords

California ,United States ,San Francisco ,Adam Mendelsohn ,Veterinary Research ,Drug Administration ,Nasdaq ,Okava Pharmaceuticals ,Health Impact ,Pharmaceuticals Inc ,Vivani Medical Inc ,Vivani Medical ,Vivani President ,Chief Executive ,Term Delivery ,Securities Litigation Reform Act ,Quarterly Report ,